Search Results

Showing results 41-51 of 92 for 'Cancer treatment'

  • lung-cancer-cells-tn
    Triple Treatment Keeps Cancer from Coming Back

    Lung cancer, the world's deadliest cancer, can be apparently successfully treated, only to return. And when it does so, it's often resistant to the drugs that worked the first time. Fortunately, Prof. Yosef Yarden has devised a novel three-pronged strategy that, in mice, kept lung cancer cells from developing resistance in the first place.

  • olfactory-fingerprint-tn
    Science Tips, June 2015

    Three updates from the the Weizmann Institute: colon cancer genes go back before moving forward, providing an opportunity for clinical intervention; UV light helps pinpoint why stars that explode as supernovas blow up in the first place; and identifying a personal olfactory ""fingerprint"" that could help screen organ donors and detect diseases such as Alzheimer's.

  • shutterstock_510072472_04ef3fdd-0d11-401a-afa3-04aa9fd44be6
    How to Mix the Perfect Cocktail

    The fine art of mixing drug cocktails - such as for cancer treatment - is incredibly complicated, especially once you get into three or more ingredients. The numbers of possible interactions and side effects are virtually infinite. Now, a new model from the lab of Prof. Uri Alon lets scientists compare combinations of drugs to determine which work well together, and with the fewest side effects. This is a major step forward in personalized medicine.

  • sela-michael-tn
    One Patent, Three Drugs

    Many years ago, Prof. Michael Sela and colleagues found that antibodies inhibiting EGFR, a receptor that plays a role in cancer, have a synergistic anti-cancer effect when used with chemotherapy. That discovery has now led to three cancer-treating drugs: Erbitux<sup>®</sup>, Vectibix<sup>®</sup>, and, most recently, Portrazza<sup>™</sup>, just FDA approved for a form of lung cancer.

  • Science Tips, January 2009

    Three research updates from the Weizmann Institute: the benefit of a uterine biopsy; creating functional nerve networks in the lab; and revealing how cancer cells survive chemotherapy.&nbsp;

  • Why Chemotherapy Fails

    Prof. Ehud Shapiro leads research that shows how leukemia can evade chemotherapy. Using his method of mapping the family trees of cells, the team found that slowly dividing cancer cells are most likely to survive the toxic therapy. This could lead to new ways of fighting cancer.

  • Science Tips, February 2013

    Three updates from the Weizmann Institute: a pre-explosion signals that a star is about to go supernova; a two-antibody approach for attacking triple-negative breast cancer; and a genetic device, operating independently in bacteria, performs DNA diagnosis.

  • bladder-cancer-tn
    A New Noninvasive Monitoring Test for Bladder Cancer

    Two Weizmann PhDs are behind Nucleix, an Israeli company that has designed a simple test for monitoring bladder cancer – the most expensive cancer to treat over a patient's lifetime. Called ""Bladder EpiCheck,"" the method is in advanced clinical trials in The Netherlands, Germany, Spain, and Israel, reports <em>Israel21c</em> – and is heading for the U.S.

  • Israelis-give-a-double-punch-to-triple-negative-cancer-thumb
    Israelis Give a Double Punch to Triple-Negative Breast Cancer

    Triple negative breast cancer targets young black or Hispanic women and those of Jewish Ashkenazi descent, and standard therapies don't work for long. In a novel approach, Weizmann scientists engineered a two-front attack by binding different antibodies to different parts of growth receptors. A vaccination against cancer is their ultimate goal.

  • Time-to-rethink-chemotherapy-thumb
    Time to Rethink Chemotherapy?

    Israel21c reports on why chemo fails. The Weizmann Institute's research on the family trees of cells sheds light on cancer recurrence and ""will likely have profound implications for the way leukemia and other cancers are treated in the future.""